MedPath

Impact of surgeon’s experience on operative outcomes of surgical prostate tissue removal.

Not Applicable
Completed
Conditions
Benign prostatic obstruction
Urological and Genital Diseases
Registration Number
ISRCTN29916004
Lead Sponsor
Rennes University Hospital, department of Urologie
Brief Summary

2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31437338/ (added 20/09/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
922
Inclusion Criteria

1. Diagnosed with lower urinary tract symptoms due to benign prostatic
obstruction (BPO)
2. Being treated with GreenLEP procedure

Exclusion Criteria

N/A

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> To be taken from the surgical reports:<br> 1. The total operative time is measured using the data from the cases.<br> 2. The probability of at least one complication during the surgery. Complications include:<br> 1.1. Capsule perforation.<br> 1.2. Bladder wall injury.<br> 1.3. Intraoperative bleeding requiring conversion to TURP or open simple prostatectomy or leading to a failed morcellation.<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Achievement of optimum outcomes in prostate enucleation will be measured using Pentafecta achievement (defined as a combination of complete enucleation and morcellation within <90 min without any conversion to standard TURP, no postoperative complications and no stress urinary incontinence) at 3 months<br> 2. Three-month postoperative symptom score reduction will be measured using the IPSS questionnaire.<br>
© Copyright 2025. All Rights Reserved by MedPath